GT Biopharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Michael Breen
Chief executive officer
US$1.5m
Total compensation
| CEO salary percentage | 36.5% |
| CEO tenure | 2.6yrs |
| CEO ownership | 1.3% |
| Management average tenure | no data |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
We're Keeping An Eye On GT Biopharma's (NASDAQ:GTBP) Cash Burn Rate
Jan 06
GT Biopharma files for $150M mixed shelf offering
Oct 13We Think GT Biopharma (NASDAQ:GTBP) Needs To Drive Business Growth Carefully
Sep 21GT Biopharma GAAP EPS of -$0.10 beats by $0.07
Aug 11Here's Why We're Watching GT Biopharma's (NASDAQ:GTBP) Cash Burn Situation
Jun 08Companies Like GT Biopharma (NASDAQ:GTBP) Are In A Position To Invest In Growth
Nov 24Getting To Know GT Biopharma
Jun 06GT Biopharma names Gregory Berk Chief Medical Officer
Apr 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$11m |
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$2m | US$556k | -US$8m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$15m |
| Mar 31 2023 | n/a | n/a | -US$16m |
| Dec 31 2022 | US$2m | US$493k | -US$21m |
| Sep 30 2022 | n/a | n/a | -US$33m |
| Jun 30 2022 | n/a | n/a | -US$32m |
| Mar 31 2022 | n/a | n/a | -US$34m |
| Dec 31 2021 | US$3m | US$63k | -US$58m |
Compensation vs Market: Michael's total compensation ($USD1.53M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Breen (61 yo)
2.6yrs
Tenure
US$1,525,834
Compensation
Mr. Michael Martin Breen serves as Interim Chief Executive Officer at GT Biopharma, Inc. since March 02, 2022. Mr. Breen serves as an Executive Chairman at GT Biopharma, Inc. since November 08, 2021 and se...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Executive Chairman | 3.8yrs | US$1.53m | 1.28% $ 57.7k | |
| Independent Director | 1.4yrs | US$218.33k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$586.00k | 0% $ 0 | |
| Independent Vice Chairman | 3.9yrs | US$586.00k | 0.53% $ 23.7k | |
| Scientific Advisor | no data | no data | no data | |
| Chairman of Science Advisory Board | 4yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | 4yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.2yrs | no data | no data |
3.8yrs
Average Tenure
74.5yo
Average Age
Experienced Board: GTBP's board of directors are considered experienced (3.8 years average tenure).